USPTO serial 79370176
DRAWRAY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2026
- Examiner
- AVENT, TEAGUE A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DRAWRAY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shenzhen Drawray Biotech Co., Ltd.
CN
Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
Shenzhen Drawray Biotech Co., Ltd.
CN
Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
Shenzhen Drawray Biotech Co., Ltd.
CN
Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
Shenzhen Drawray Biotech Co., Ltd.
CN
Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road, Suite 100No. 6 Zhujiang East Road,Henderson, NV 89014Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for the diagnosis of pregnancy; preparations of microorganisms for medical and veterinary use; antiseptics; diagnostic preparations for medical purposes; biological preparations for medical purposes for analyzing human body fluids and excreta; biological preparations for medical purposes for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; enzyme preparations for medical purposes; chemical preparations for medical purposes for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; dietetic substances adapted for medical use, namely, dietary supplements | ACTIVE | — |
| 009 | Computer program in the nature of downloadable software for operating medical diagnostic equipment; biometric scanners; weighing machines; surveying apparatus and instruments; diagnostic apparatus, not for medical purposes for food safety testing; Chemistry apparatus and instruments, namely, diagnostic apparatus for food safety testing; Testing apparatus not for medical purposes, namely, diagnostic apparatus for food safety testing; measuring vessels or apparatus for physical and chemical test and for component analysis use in the nature of measuring cups; battery charging devices; video disks with recorded animated cartoons | ACTIVE | — |
| 010 | Apparatus for use in medical analysis, namely, apparatus for analyzing human body fluids and excreta for medical use; Apparatus for use in medical analysis, namely, apparatus for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; diagnostic apparatus for medical purposes, namely, diagnostic apparatus for analyzing human body fluids and excreta for medical use; diagnostic apparatus for medical purposes, namely, apparatus for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; medical apparatus and instruments, namely, apparatus and instruments for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; testing apparatus for medical purposes for analyzing human body fluids and excreta for medical use; testing apparatus for medical purposes, namely, apparatus and instruments for screening of anemia, screening of metabolic diseases, screening of thrombotic diseases, liver function assessment and disease diagnosis, growth and development assessment, reproductive hormone analysis, gastric function disease diagnosis, tumor marker diagnosis, cardiovascular and cerebrovascular disease risk assessment, inflammatory disease monitoring, thyroid function, brain injury detection, autoimmune disease detection, allergen detection, Alzheimer's disease detection; dental apparatus and instruments, namely, X-ray apparatus for medical use; lasers for medical purposes; isotopic equipment and devices used in medical diagnosis and treatment, namely, X-ray apparatus for medical use; hearing aids; intra-uterine contraceptive devices; orthopaedic articles, namely, orthopaedic belts | ACTIVE | — |
| 035 | Advertising services; business management assistance; import-export agency services; personnel management; commercial business relocation, namely, business administrative services for the relocation of businesses; systemization of information into computer databases; accounting; rental of vending machines; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies | ACTIVE | — |
| 042 | Quality control for others; packaging design; graphic arts design | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
- Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
- Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
- Other trademarks owned by Shenzhen Drawray Biotech Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named DRAWRAY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 1, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 31, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 8, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 8, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 8, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 28, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 7, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 19, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 19, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 19, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Nov 9, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 9, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 23, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 4, 2023 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Sep 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 30, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |